Company profile for Inspyr Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Developing targeted cancer therapeutics that delivers a potent, unique & patented drug that directly treats breast, prostate, bladder, kidney, and lung cancer. Our innovative approach to drug delivery is expected to maximize anti-tumor activity while minimizing side effects with the best way to cure or extend human life. According to the International Agency for Research on Cancer (IARC), in 2018 there were an estimated 17.0 m...
Developing targeted cancer therapeutics that delivers a potent, unique & patented drug that directly treats breast, prostate, bladder, kidney, and lung cancer. Our innovative approach to drug delivery is expected to maximize anti-tumor activity while minimizing side effects with the best way to cure or extend human life. According to the International Agency for Research on Cancer (IARC), in 2018 there were an estimated 17.0 million new cancer cases and 9.6 million cancer deaths worldwide.In 2019 in the U.S., there will be an estimated 1,762,450 new cancer cases and 606,880 cancer deaths.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2511 North Loop 1604 West, Suite 204 San Antonio, TX 78258
Telephone
Telephone
1-210-479-8112
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BioProcess International US West

Not Confirmed

envelop Contact Supplier

BioProcess International US West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/article/releases/inspyr-therapeutics-further-strengthens-global-intellectual-property/#:~:text=Inspyr%20Therapeutics%20Further%20Strengthens%20Global%20Intellectual%20Property,-Published%3A%20Feb%2018&text=WESTLAKE%20VILLAGE%2C%20CA%20%2F%20ACCESSWIRE%20%2F,Known%20As%20GenSpera)%2C%20Inc.&text=The%20issued%20Eurasia%20patent%20and,company's%20global%20intellectual%20property%20portfolio.

BIOSPACE
18 Feb 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty